Hospital
Thedacare Regional Medical Center - Appleton, INC.
Thedacare Regional Medical Center - Appleton, INC. was paid $429K by Medicaid between Jan 2018 and Dec 2024, across 77 billing codes. Its largest line is 96413, Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance — 27% of everything it billed.
33Billing provider infoTHEDACARE REGIONAL MEDICAL CENTER - APPLETON, INC.
APPLETON, WI 54911
APPLETON, WI 54911
33aNPI1689038408assigned 04/07/2016
33bProvider typeGeneral Acute Care Hospital
28Total paid$429K
24GClaims86,148
24DCodes billed77
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Wisconsin
Rank by total paid#49 of 60
Median peer was paid$2.90M
This provider vs. median0.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official FLETT, WILLIAM controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,406 | $57K | |
| 2019 | 7,123 | $62K | |
| 2020 | 8,340 | $82K | |
| 2021 | 19,849 | $125K | |
| 2022 | 27,425 | $89K | |
| 2023 | 11,288 | $11K | |
| 2024incomplete | 5,717 | $3K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 27% | 2,674 | 1,233 | $115K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 14% | 955 | 365 | $62K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 6.8% | 2,138 | 723 | $29K |
| 80048 | Basic metabolic panel (calcium, ionized) | 6.5% | 10,984 | 6,088 | $28K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 6.3% | 11,427 | 6,444 | $27K |
| 80076 | 4.7% | 7,780 | 4,289 | $20K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 4.1% | 2,201 | 878 | $17K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 3.1% | 114 | 68 | $13K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 3.0% | 1,350 | 779 | $13K |
| 84443 | Thyroid stimulating hormone (TSH) | 3.0% | 2,557 | 1,994 | $13K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.8% | 461 | 326 | $8K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.8% | 1,019 | 820 | $8K |
65 more codes
| 80061 | Lipid panel | 1.7% | 1,665 | $7K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.3% | 461 | $5K |
| 95811 | 1.2% | 12 | $5K | |
| 96367 | 1.0% | 355 | $4K | |
| 82728 | <1% | 1,092 | $4K | |
| 87480 | <1% | 365 | $4K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,064 | $4K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,155 | $3K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 72 | $3K |
| 87510 | <1% | 370 | $2K | |
| 87660 | <1% | 243 | $2K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 7,258 | $2K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,446 | $2K |
| 84439 | <1% | 1,102 | $2K | |
| 82607 | <1% | 398 | $2K | |
| 83615 | <1% | 496 | $2K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 125 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 445 | $1K |
| 80306 | <1% | 160 | $1K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,142 | $1K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 657 | $1K |
| 84481 | <1% | 484 | $1K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 16 | $1K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 97 | $938.80 |
| 83550 | <1% | 503 | $822.73 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 134 | $778.16 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 68 | $683.37 |
| 77336 | <1% | 76 | $666.95 | |
| 83540 | <1% | 506 | $653.54 | |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 16 | $601.60 |
| 81001 | <1% | 472 | $538.81 | |
| 86140 | <1% | 325 | $495.22 | |
| 83735 | <1% | 405 | $473.04 | |
| 85027 | <1% | 228 | $460.83 | |
| 36591 | <1% | 74 | $449.80 | |
| J1750 | Injection, iron dextran, 50 mg | <1% | 24 | $420.97 |
| 82043 | <1% | 169 | $396.84 | |
| 81025 | <1% | 129 | $386.68 | |
| 82570 | <1% | 195 | $382.68 | |
| 85610 | <1% | 355 | $370.38 | |
| 84460 | <1% | 290 | $359.82 | |
| 85651 | <1% | 256 | $359.00 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 15 | $316.86 |
| 86780 | <1% | 60 | $259.88 | |
| 82565 | <1% | 290 | $231.43 | |
| 87340 | <1% | 31 | $179.44 | |
| 86803 | <1% | 19 | $158.54 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 314 | $146.38 |
| 36415 | Collection of venous blood by venipuncture | <1% | 13,354 | $143.62 |
| 82947 | <1% | 89 | $138.57 | |
| 87070 | <1% | 53 | $96.09 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 37 | $80.00 |
| 87186 | <1% | 38 | $71.76 | |
| 81003 | <1% | 96 | $68.73 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 98 | $60.38 |
| 83690 | <1% | 14 | $55.12 | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 55 | $33.10 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 2,465 | $33.00 |
| 84450 | <1% | 33 | $31.88 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 212 | $29.88 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 167 | $25.76 |
| 87088 | <1% | 15 | $25.47 | |
| 84165 | <1% | 20 | $22.12 | |
| J1756 | Injection, iron sucrose, 1 mg | 0% | 81 | $0.00 |
| 96415 | 0% | 27 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFLETT, WILLIAM (CFO)
Parent organizationTHEDACARE REGIONAL MEDICAL CENTER, APPLETON, INC.
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.